The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A health-related quality-of-life (HRQoL) analysis of pomalidomide + low-dose dexamethasone + daratumumab in relapsed refractory multiple myeloma (RRMM) after lenalidomide treatment.
 
Donna Ellen Reece
Honoraria - Amgen; Celgene; Janssen; Merck; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Merck; Takeda
Research Funding - Amgen; Celgene; Janssen; Merck; Otsuka; Takeda
Other Relationship - Celgene; Janssen
 
Nizar J. Bahlis
Honoraria - Amgen; Celgene; Janssen
Consulting or Advisory Role - Amgen; Celgene; Janssen
Research Funding - Amgen; Celgene; Janssen
 
Christy Joy Samaras
No Relationships to Disclose
 
Michael Sebag
Other Relationship - Amgen; Celgene; Janssen; Takeda
 
Jesus G. Berdeja
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Glenmark (Inst); Janssen (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst)
 
Siddartha Ganguly
Honoraria - Amgen; Daiichi Sankyo; Janssen; Kite, a Gilead company; Seagen
Consulting or Advisory Role - Amgen; Kite, a Gilead company
Speakers' Bureau - Seagen
Research Funding - Daiichi Sankyo (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo; Kite, a Gilead company; Seagen
 
Jeffrey Matous
Honoraria - Celgene
Consulting or Advisory Role - Celgene; Pharmacyclics
Speakers' Bureau - Celgene
Research Funding - Celgene (Inst); Seagen (Inst)
 
Kevin W. Song
Honoraria - Amgen; Celgene; Janssen; Takeda
Research Funding - Amgen; Celgene; Janssen; Takeda
 
Christopher Seet
No Relationships to Disclose
 
Giampaolo Talamo
No Relationships to Disclose
 
Mirelis Acosta-Rivera
No Relationships to Disclose
 
Michael Bar
Consulting or Advisory Role - Celgene
 
Donald Quick
Research Funding - CTI BioPharma Corp
 
Bertrand Marquess Anz
No Relationships to Disclose
 
Gustavo A. Fonseca
Employment - Florida Cancer Specialists
Honoraria - Amgen; Celgene
Speakers' Bureau - Amgen; Celgene
Research Funding - Amgen (Inst); Celgene (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Celgene
 
Amit Agarwal
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Weiyuan Chung
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Faiza Zafar
Employment - Celgene
 
David Samuel DiCapua Siegel
Stock and Other Ownership Interests - Celularity
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Karyopharm Therapeutics; Merck; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen Oncology; Takeda
Research Funding - Celgene (Inst)